PRNP and Alzheimer disease: Most studies have utilized transgenic mice overexpressing AD-causing variants of APP and PSEN1, and found necessity of PrPC for synapse loss, memory deficits and selective neuronal degeneration using anti-PrPC antibody blockade or PrP antagonists or gene knockout [12–17].